Does Vitamin D Alter Bone's Response to Vibration?

January 3, 2020 updated by: Sheffield Children's NHS Foundation Trust

Does Antenatal Vitamin D Supplementation Influence Bone's Postnatal Response to Mechanical Stimulation?

Fractures in children are common and the incidence is increasing. They are more common in children who have small, narrow and weak bones. Studies have shown that fractures in early childhood are associated with later bone strength.

There are several (i) non-modifiable (age, gender, race, genetics) and (ii) modifiable factors such as nutrition (vitamin D & calcium intake) and exercise that can contribute to bone strength.

Low calcium is associated with an increased risk of fracture. Vitamin D plays a pivotal role in bone health by increasing the absorption of calcium from the gut. Investigators know from the previous research that there is a reduction in bone strength in children whose mothers had lower vitamin D levels during pregnancy.

Bone growth can also be achieved by loading of bone during childhood in the form of regular sport activities such as gymnastics and exercise programmes. Equally it can be achieved by using whole body vibration (WBV). WBV is the application of vibratory stimulus to the body in a synchronous fashion by which the bones are made much stronger reducing the risk of fracture in later life. Thus WBV can be used as a means to assess bone responsiveness to mechanical stimulation. Studies have shown that standing on a vibrating platform for 10 minutes a day can significantly increase the bone mass. Investigators' own research has also shown that healthy boys when made to stand on a vibration platform for 10 minutes daily for 5 days increased the strength and quality of their bones.

Thus the role of diet and mechanical loading are of considerable interest in determining their role in bone health and the prevention of fractures.

Maternal Vitamin D Osteoporosis Study (MAVIDOS) is a large study conducted recently at 3 different big centres (Sheffield, Southampton and Oxford). Results from this study have shown that giving a higher dose of vitamin D to pregnant women every day from 14 weeks of pregnancy increased the strength of the bones in their infants. In the proposed study Investigators aim to show how vitamin D supplementation during pregnancy affects the response of bone to vibration in children whose mothers participated in the MAVIDOS study in Sheffield. These children will be 4 years of age when they participate in this study.

The results of this study will help inform public health policy on vitamin D intake during pregnancy. This will also help the investigators identify a possible risk factor for poor bone health in children.

Study Overview

Detailed Description

This project aims to determine whether antenatal vitamin D supplementation alters postnatal bone formation in response to mechanical stimulation.

The skeleton responds to mechanical stimulation by an increase in bone size and mass and that increment can persist into adult life and may lower the risk of osteoporosis (Daly, & Bass, 2009). In contrast, without mechanical stimulation, bone is lost.

Cells within bone - osteoblasts and osteoclasts - are involved in the removal and formation of bone; the biomarkers Pro-collagen type 1 N-terminal propeptide (PINP) and C-terminal cross-linked telopeptide of type I collagen (CTx) are surrogates for their respective tissue level activities.

Whole body vibration (WBV) has been used as one of the methods to deliver mechanical stimulation in both adults and children.

The investigators have recently shown in healthy boys aged 9-11 years, WBV experienced 10 minutes daily for five days increases the P1NP by 25% and CTx by 11% (Harrison et al., 2015).

The investigators undertook another study recently to determine the effect of reduced vitamin D intake during pregnancy and early life on the skeleton's response to mechanical loading using a mouse model.

Our unpublished data show that antenatal vitamin D depletion substantially reduces the loading-dependent increase in both cortical and trabecular bone mass of offspring mice close to skeletal maturity.

The available human and mouse data suggest that antenatal vitamin D deficiency in some way influences the bone to become less responsive to mechanical stimulation.

The investigators are now ready to explore this in humans, to assess the responsiveness of the skeleton to mechanical stimulation by using WBV in the children who have been exposed to higher levels of vitamin D in-utero through maternal supplementation of vitamin D.

Through this study the investigators will be able to determine whether the in-utero environment can be modified easily to improve the skeletal responsiveness to activity and this improved skeletal health in the short and long term.

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Sheffield (South Yorkshire District)
      • Sheffield, Sheffield (South Yorkshire District), United Kingdom, S10 2TH
        • Sheffield Children's NHS Foundation Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

4 years to 5 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All children born to mothers who participated in MAVIDOS trial in Sheffield free from any condition affecting bone health, general nutrition, growth and glucose metabolism will be invited to enrol in the study.

Exclusion Criteria:

  • Children with (1) balance problems, (2) current or healing fractures (3) any chronic illness involving the bone, liver and kidney (4) current long-term use of steroids, anticonvulsants or any medication that might affect calcium and vitamin D metabolism will be identified from through a questionnaire and excluded.
  • Participants will fill in questionnaires to estimate their calcium intake and Vitamin D exposure and this will be included in the analysis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Vitamin D group
Children born to mothers who received vitamin D during pregnancy will undergo mechanical stimulation using whole body vibration(WBV) by standing on the vibration platform(LivMd) for 10 minutes on 5 consecutive mornings, at 7.30-8 am.
All participants will undergo whole body vibration (WBV) by standing on the LivMD WBV platform on 5 consecutive mornings
Placebo Comparator: Placebo group
Children born to mothers who received placebo during pregnancy will also undergo mechanical stimulation using whole body vibration(WBV) by standing on the vibration platform (LivMd) for 10 minutes on 5 consecutive mornings, at 7.30-8 am.
All participants will undergo whole body vibration (WBV) by standing on the LivMD WBV platform on 5 consecutive mornings

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Difference in mean increase in the bone turnover marker Pro-collagen type 1 N-terminal propeptide (P1NP) between children born to antenatally vitamin D replete mothers versus antenatally vitamin D deficient mothers.
Time Frame: 2 years
2 years

Secondary Outcome Measures

Outcome Measure
Time Frame
Change in C-terminal cross-linked telopeptide of type I collagen(CTx)
Time Frame: 2 years
2 years
Change in Osteoprotegerin(OPG).
Time Frame: 2 years
2 years
Change in parathyroid hormone (PTH).
Time Frame: 2 years
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 19, 2016

Primary Completion (Actual)

March 1, 2018

Study Completion (Actual)

March 1, 2018

Study Registration Dates

First Submitted

April 5, 2016

First Submitted That Met QC Criteria

April 14, 2016

First Posted (Estimate)

April 19, 2016

Study Record Updates

Last Update Posted (Actual)

January 7, 2020

Last Update Submitted That Met QC Criteria

January 3, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vitamin D Deficiency

Clinical Trials on Mechanical Stimulation using whole body vibration

Subscribe